商铺首页
公司详情
产品陈列室
联系方式
基本信息
企业名称
朗坤集团
企业地址
浙江省杭州市浙江省杭州市西湖区紫霞街道西溪谷商务中心D座10层
成立日期
2011
企业规模(人)
20至29
年销售额(USD)
不愿意公开
企业简介
朗坤总部位于中国香港,包括在大陆&香港和欧洲的分公司,以及欧美日本和国内的合作伙伴;2020年10月份成立以研发合成基地-安庆朗坤药业;我们的业务领域从进口化工原料,优良制剂和保健品,再到自主研发,组织生产,和国内外注册、销售;同时我们也在逐步完善自身产业链和团队的功能,积极务实地拓展大健康事业。 朗坤是一个年轻的公司,但是我们汇聚了长期从事医药健康事业的专业团队,包含了新药研发,原料药,制剂注册,专利申请,生产,销售,财务,法务等顾问和合伙人。
主要竞争优势
国际认证/标准,产品线丰富,接受买家的规格要求,接受小额订单,良好的信誉,优质服务
邮政编码
310030
贸易信息
业务类型
出口商,进口商,贸易公司,服务商
主要销售市场
中国,中/南美洲,东欧,亚洲
主营产品类别
原料药,中间体,生物制品,天然提取物,药品制剂
参展信息
主营产品
5-Nitroisophthalic acid(618-88-2);Dimethyl 5-nitroisophthalate(13290-96-5);Acetoxyacetyl chloride(13831-31-7);(S)-(-)-2-Acetoxypropionyl Chloride(36394-75-9);Methoxyacetyl chloride(38870-89-2);3-Amino-1,2-propanediol(616-30-8);ATIBA(76801-93-9);5-(Acetamido)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiono-1,3-benzenedicar boxamide(31127-80-7);5 - chloro-acetamido-N, N - bis (2,3 - dihydroxypropyl) -2,4,6 - triiodo-1 ,3. Phthalimido(77203-11-3);S-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-amino-2,4,6-triiodo-1,3-benzenedicarboxamide(60166-98-5);Cyclen(294-90-6);DOTA(60239-18-1);5-Amino-N,N'-bis(2,3-dihydroxypropyl) isophthaldiamide(76820-35-4);5-Amino-2,4,6-triiodisophtha loyl acid dichloride(37441-29-5);4-Carboxy-5,8,11-tris(carbox ymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oic acid(113786-33-7);GDB2(138168-36-2);GBD1(156077-56-4);BMC(4876-10-2);DMAP(1122-58-3);SAMe(97540-22-2);3'-Chloropropiophenone(34841-35-5);5-Isopropylhydantoin(16935-34-5);Phenoxyacetic Acid Sodium(313222-85-4);3-Pyridinesulfonic acid(636-73-7);Sitagliptin(486460-32-6);Vitamin D2(50-14-6);Vitamin D3(67-97-0);Vitamin K1(84-80-0);Diquafosol sodium(211427-08-6);Migalastat hydrochloride(75172-81-5);Iohexol(66108-95-0);Ioversol(87771-40-2);Iopamidol(60166-93-0);Vonoprazan(881681-00-1);Perfluoro-2-methylpentane(355-04-4);1,1,1,2,3,4,4,5,5,5-Decafluoro-3-methoxy-2-(trifluoromethyl)pentane(132182-92-4);Methyl perfluoro butyl ether(163702-08-7);Ethyl Nonafluorobutyl Ether(163702-05-4);2,3,3,3-tetrafluoro-1,1 bis[1,2,2,2-tetrafluoro 1(trifluoromethyl)ethyl]-2-(2,2,2-trifluoroethoxy,propyl(176374-91-7);Perfluorotri-n-butylamine(86508-42-1);1-(Perfluorohexyl)octane(133331-77-8);Hexafluoro benzene(392-56-3);Pentafluoro phenol(771-61-9);Octafluorotoluene(434-64-0);Chloropentafluorobenzene(344-07-0);Pentafluoro benzene(363-72-4);Tetrafluoro benzene(327-54-8);3,3,3-trifluoro-1-propanol(2240-88-2);4-bromo-3,3,4,4-tetraFluoro-1-butanol(234443-21-1);Bisphenol S(80-09-1);5-Aminotetrazole(4418-61-5);Fmoc-AEEA(166108-71-0);FmocNH-PEG8-C2-COOH(756526-02-0);NH2-PEG8-C2-COOH(756526-04-2);Amino-PEG8-C2-Azido(857891-82-8);Propargyl-PEG6-C2-COOH(2093154-00-6);Propargyl-PEG7-C2-CONHS ester(2182601-74-5);Biotin PEG4-Propargyl(1262681-31-1);Mal-PEG4-C2-COOH(518044-41-2);Fmoc-Val-Ala-OH(150114-97-9);Fmoc-Val-Ala-PAB-OH(1394238-91-5);Fmoc-GLY-GLY-PHE-GLY-OH(1817857-75-2);Acid-PEG4-t-butyl ester(1835759-85-7);Furil(492-94-4);9,10-Dibutoxyanthracene(76275-14-4);Pomalidomide-PEG5-C2-COOH(2139348-63-1);Pomalidomide-C5-COOH(2225940-49-6);Monomethyl 5-Nitroisophthalate(1955-46-0);Gadolinium oxide(12064-62-9);(((9H-fluoren-9-yl)methoxy)carbonyl)glycylglycine(35665-38-4);Alfacalcidol(41294-56-8);Calcitriol(32222-06-3);Heptafluoroisopropyl iodide(677-69-0);4-Bromo-2-fluorobiphenyl(41604-19-7);(S)-1-Boc-3-hydroxypiperidine(143900-44-1);3-Iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine(151266-23-8);2'-O-Methyluridine(2140-76-3);2-Nitrophenyl-beta-D-galactopyranoside(369-07-3);3-Chloro-1,2-propanediol(96-24-2);Barbituric acid(67-52-7);3''-AMINO-2''-HYDROXY-BIPHENYL-3-CARBOXYLIC ACID(376592-93-7);4-(4-Chloro-2-thienyl)-2-thiazolamine(570407-10-2);(R)-(+)-2-Methyl-2-propanesulfinamide(196929-78-9);(S)-(-)-2-Methyl-2-propanesulfinamide(343338-28-3);Triphenyl(propyl)phosphonium bromide(6228-47-3);(5-fluoro-2,3-dihydrobenzofuran-4-yl)methanamine hydrochloride(2135600-87-0);Carbamic acid, N-[(1S)-2-(4-bromo-2-fluorophenyl)-1-cyanoethyl]-, 1,1-dimethylethyl ester(1628471-89-5);2-Ethoxyethanol(110-80-5);CALCIFEDIOL(19356-17-3);Iodixanol(92339-11-2);Ibrutinib(936563-96-1);Sitagliptin(486460-32-6);Resmetirom(920509-32-6);Upadacitinib(1310726-60-3);Diquafosol sodium(211427-08-6);Vonoprazan fumarate(1260141-27-2);Pantoprazole Sodium(138786-67-1);Valsartan/Sacubitril (1:1)(936623-90-4);Arotinolol HCL(68377-91-3);Landiolol HCL( 144481-98-1);CAPTOPRIL(62571-86-2);METHYLDOPA( 555-30-6);Sulodexide(57821-29-1);Micafungin Sodium(208538-73-2);CASPOFUNGIN ACETATE(179463-17-3);SIROLIMUS (RAPAMYCIN)(53123-88-9);ACEXAMIC ACID(57-08-9);CARBIDOPA(38821-49-7);LEVODOPA(59-92-7);Avibactam sodium(1192491-61-4);Ozenoxacin(245765-41-7);Migalastat(108147-54-2)
参展展会
第二十三届世界制药原料中国展
展会时间
2025-03-06至2025-07-31
展位号
W4C20
展品分类
Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals;Veterinary Drug & Feed Additives;Pharma Logistics
参展信息
×